-
AASLD Interview | Dr. Jian Wu’s Research Group at Fudan University Shanghai Medical College Shares Highlights and Insights from AASLD 2023
Since 1997, Professor Jian Wu’s research group at Fudan University Shanghai Medical College has been actively participating in the annual meeting of the American Association for the Study of Liver Diseases (AASLD 2023). This year, the research group has had four abstracts selected for poster presentations and one abstract chosen for an oral presentation in…
-
Multiple Studies on Antiviral Treatment for Chronic Hepatitis B Selected for Conference Exchange, with a Focus on the Stability of Decompensation
From November 10th to 14th, 2023, the American Association for the Study of Liver Diseases (AASLD) Annual Meeting was grandly held in Boston, USA. In this event, Dr. Wen Xie’s team from Beijing Ditan Hospital, Capital Medical University, presented several notable research findings. One of them is a study on the stability of decompensation in…
-
Dr. Jing Zhang: Team’s 7 Achievements in the Fields of Fatty Liver, Cirrhosis, and Hepatitis C, Research Insights, and Future Directions
From November 10th to 14th, 2023, the American Association for the Study of Liver Diseases (AASLD) Annual Meeting 2023 was held in Boston, USA. Professor Jing Zhang and her team from Beijing Youan Hospital, Capital Medical University, have long focused on scientific research in chronic liver diseases. Seven research findings from the team were included…
-
AASLD Voice of China | Dr. Hong Tang’s Team: Multiple Research Achievements in the Fields of Hepatitis B, Hepatitis C, and Non-Alcoholic Fatty Liver D
From November 10th to 14th, 2023, the American Association for the Study of Liver Diseases Annual Meeting (AASLD2023) was held in Boston, USA. Professor Hong Tang’s team from West China Hospital of Sichuan University presented multiple research studies in the fields of hepatitis B, hepatitis C, and non-alcoholic fatty liver disease (NAFLD) at the conference.…
-
AASLD 2023丨Landmark Chinese Study on NASH Treatment Presented at AASLD
On November 11, 2023, at the American Association for the Study of Liver Diseases annual meeting (AASLD 2023), the results of China’s first international registered randomized controlled trial (RCT) evaluating therapeutic efficacy through liver histology, known as the VENS study, were showcased in poster format. This presentation garnered significant attention and discussions from international experts…
-
Focusing on Hepatitis B, New Developments in the “Oasis” Project and Exploration of TAF’s Immune Modulation Effects
The annual highlight in the field of hepatology, the 2023 American Association for the Study of Liver Diseases (AASLD) Annual Meeting, is currently taking place in Boston, USA. Two research achievements related to the treatment and management of hepatitis B by Dr. Wenhong Zhang and Dr. Jiming Zhang ‘s team from Huashan Hospital, affiliated with…
-
Presentation of Research Achievements in Liver Transplantation and New Insights into Liver Transplantation Progress
From November 10th to 14th, 2023, the annual grand event in the field of hepatology, the American Association for the Study of Liver Diseases Annual Meeting (AASLD2023), took place in Boston, USA. The on-site reporting team of “Hepatology Digest” had the privilege of inviting Dr. Wei Rao’s team from the Organ Transplant Center of Qingdao…
-
AASLD Voice of China | Dr. Liang Peng’s Team: Release of Clinical and Basic Research Results on Multiple Hepatitis B Studies, Preliminary Confirmation
From November 10th to 14th, 2023, the annual international highlight event in the field of hepatology, the 2023 American Association for the Study of Liver Diseases (AASLD) Annual Meeting, is being held in Boston, USA. Dr. Liang Peng’s team from the Third Affiliated Hospital of Sun Yat-sen University has had multiple research results included in…
Connecting Medical Expertise through Media